Professional use for Boehringer's Coaguchek:
This article was originally published in Clinica
Boehringer Mannheim's CoaguChek system, used for monitoring warfarin anticoagulation therapy, has received waived status under the Centres for Disease Control and Prevention's Clinical Laboratory Improvement Amendments. The waiver allows healthcare providers to use the system without the need to comply with regulations. Manufacturers' instructions will be followed to perform the test.
You may also be interested in...
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.